Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of paclitaxel + lobaplatin versus paclitaxel + carboplatin in advanced non-small cell lung cancer
ChiCTR-TRC-11001223Phase 3Completed
- Sponsor
- Nanjing Bayi Hospital
- Start
- Jan 2011
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lobaplatin, carboplatin, paclitaxel in non-small cell lung cancer (NSCLC), sponsored by Nanjing Bayi Hospital. Started Jan 2011; status: completed.
02
Drugs
lobaplatincarboplatinpaclitaxel
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on ChiCTR-TRC-11001223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001223.